Richmond Pharmacology is excited to announce that Dr. Jörg Taubel, along with colleagues Nobuo Ittetsu and Minoru Takada, will be attending the 21st DIA Japan Annual Meeting 2024. This event, held in Tokyo from 27th to 29th October, brings together global leaders in drug development and regulatory science.

The conference will focus on "Driving Patient-Centric Innovation" and offers a unique opportunity for industry professionals to engage in high-level discussions on the latest advancements in drug development, regulatory trends, and innovative technologies in healthcare.

As an attendee, Dr. Taubel will be contributing to the dialogue on cutting-edge clinical research practices. If you would like to connect with us during the event, please feel free to reach out and arrange a meeting.

For more information about the event, please visit the DIA Japan Annual Meeting 2024 website.

Latest news

Accelerated Pathways: How ILAP Gives Developers a Strategic Early Advantage

January 29, 2026
The pace of medical innovation is faster than ever, but patients often face delays in accessing transformative therapies.
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event